Phibro Animal Health (PAHC) Net Cash Flow (2016 - 2025)
Phibro Animal Health has reported Net Cash Flow over the past 13 years, most recently at -$16.8 million for Q4 2025.
- Quarterly results put Net Cash Flow at -$16.8 million for Q4 2025, down 188.84% from a year ago — trailing twelve months through Dec 2025 was -$13.0 million (down 134.38% YoY), and the annual figure for FY2025 was -$1.4 million, down 104.38%.
- Net Cash Flow for Q4 2025 was -$16.8 million at Phibro Animal Health, down from $4.6 million in the prior quarter.
- Over the last five years, Net Cash Flow for PAHC hit a ceiling of $23.1 million in Q4 2021 and a floor of -$31.2 million in Q1 2023.
- Median Net Cash Flow over the past 5 years was $3.0 million (2022), compared with a mean of $1.3 million.
- Biggest five-year swings in Net Cash Flow: skyrocketed 755.51% in 2022 and later plummeted 1010.17% in 2024.
- Phibro Animal Health's Net Cash Flow stood at $23.1 million in 2021, then crashed by 137.13% to -$8.6 million in 2022, then grew by 6.7% to -$8.0 million in 2023, then skyrocketed by 336.3% to $18.9 million in 2024, then crashed by 188.84% to -$16.8 million in 2025.
- The last three reported values for Net Cash Flow were -$16.8 million (Q4 2025), $4.6 million (Q3 2025), and $6.5 million (Q2 2025) per Business Quant data.